Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
The Journal of Biological Chemistry
|
March 19, 2020
Noncatalytic Bruton's tyrosine kinase activates PLCγ<sub>2</sub> variants mediating ibrutinib resistance in human chronic lymphocytic leukemia cells
Martin Wist, Laura Meier, Orit Gutman, et al.
Oncotarget
|
October 23, 2018
Functional characterization of phospholipase C-γ<sub>2</sub> mutant protein causing both somatic ibrutinib resistance and a germline monogenic autoinflammatory disorder
Claudia Walliser, Martin Wist, Elisabeth Hermkes, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 13, 2010
A new missense mutation in the leptin gene causes mild obesity and hypogonadism without affecting T cell responsiveness
Pamela Fischer-Posovszky, Julia von Schnurbein, Barbara Moepps, et al.
European Journal of Endocrinology
|
December 24, 2016
Measurement of immunofunctional leptin to detect and monitor patients with functional leptin deficiency
Martin Wabitsch, Lutz Pridzun, Michael Ranke, et al.
Molecular Cell
|
April 28, 2009
Structural insights into formation of an active signaling complex between Rac and phospholipase C gamma 2
Tom D Bunney, Olaniyi Opaleye, S Mark Roe, et al.
Molecular and Cellular Biology
|
January 20, 2011
Membrane environment exerts an important influence on rac-mediated activation of phospholipase Cγ2
Katy L Everett, Anja Buehler, Tom D Bunney, et al.
Molecular Cell
|
February 18, 2006
Structural and mechanistic insights into ras association domains of phospholipase C epsilon
Tom D Bunney, Richard Harris, Natalia Lamuño Gandarillas, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 18, 2015
Severe Early-Onset Obesity Due to Bioinactive Leptin Caused by a p.N103K Mutation in the Leptin Gene
Martin Wabitsch, Jan-Bernd Funcke, Julia von Schnurbein, et al.
Blood Advances
|
June 9, 2026
PLCG2 Exon-Skipped Variants: Insights into Their Potential Role in Chronic Lymphocytic Leukemia
Jialei Qi, Wen Li, Rashmi Priyadharshini Dheenadayalan, et al.
Blood
|
October 18, 2021
Evaluation of vecabrutinib as a model for noncovalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemia
Billy Michael Chelliah Jebaraj, Annika Müller, Rashmi Priyadharshini Dheenadayalan, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
The Journal of Biological Chemistry
|
March 19, 2020
Noncatalytic Bruton's tyrosine kinase activates PLCγ<sub>2</sub> variants mediating ibrutinib resistance in human chronic lymphocytic leukemia cells
Martin Wist, Laura Meier, Orit Gutman, et al.
Oncotarget
|
October 23, 2018
Functional characterization of phospholipase C-γ<sub>2</sub> mutant protein causing both somatic ibrutinib resistance and a germline monogenic autoinflammatory disorder
Claudia Walliser, Martin Wist, Elisabeth Hermkes, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 13, 2010
A new missense mutation in the leptin gene causes mild obesity and hypogonadism without affecting T cell responsiveness
Pamela Fischer-Posovszky, Julia von Schnurbein, Barbara Moepps, et al.
European Journal of Endocrinology
|
December 24, 2016
Measurement of immunofunctional leptin to detect and monitor patients with functional leptin deficiency
Martin Wabitsch, Lutz Pridzun, Michael Ranke, et al.
Molecular Cell
|
April 28, 2009
Structural insights into formation of an active signaling complex between Rac and phospholipase C gamma 2
Tom D Bunney, Olaniyi Opaleye, S Mark Roe, et al.
Molecular and Cellular Biology
|
January 20, 2011
Membrane environment exerts an important influence on rac-mediated activation of phospholipase Cγ2
Katy L Everett, Anja Buehler, Tom D Bunney, et al.
Molecular Cell
|
February 18, 2006
Structural and mechanistic insights into ras association domains of phospholipase C epsilon
Tom D Bunney, Richard Harris, Natalia Lamuño Gandarillas, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 18, 2015
Severe Early-Onset Obesity Due to Bioinactive Leptin Caused by a p.N103K Mutation in the Leptin Gene
Martin Wabitsch, Jan-Bernd Funcke, Julia von Schnurbein, et al.
Blood Advances
|
June 9, 2026
PLCG2 Exon-Skipped Variants: Insights into Their Potential Role in Chronic Lymphocytic Leukemia
Jialei Qi, Wen Li, Rashmi Priyadharshini Dheenadayalan, et al.
Blood
|
October 18, 2021
Evaluation of vecabrutinib as a model for noncovalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemia
Billy Michael Chelliah Jebaraj, Annika Müller, Rashmi Priyadharshini Dheenadayalan, et al.
Page
of 6